An Australia study detected MALToma patients with H. pylori from 1997 to 2014 and concluded CLA-resistance rate was as low as 15%, which supported eradication regimens containing CLA (Bilgilier et al., 2016). This evidence concerns the gene SELPLG and MALT lymphoma.